Trinity Capital announced the commitment of $30 million in growth capital to Elucent Medical ("Elucent"), a pioneering medical technology company transforming the field of guided surgical technologies.Elucent amplifies the field of surgical guidance...
Read Story
January 28, 2025, 08:12 AM
|
Trinity Capital announced the commitment of $15 million in growth capital to restor3d, a 3D printing, patient specific medical device company. The new debt facility from Trinity will allow restor3d to continue its product innovation and expansion...
Read Story
June 06, 2024, 08:00 AM
|